When to treat the pelvis in node-positive vulvar cancer: Results from the AGO-VOP.2 QS vulva study

Hampl M, Jaeger A, Eulenburg C, Prieske K, Hambrecht J, Fuerst S, Klapdor R, Heublein S, Gaß P, Rohner A, Canzler U, Becker S, Bommert M, Bauerschlag D, Denecke A, Hanker L, Sehouli J, Dannecker C, Mahner S, Woelber L (2022)


Publication Type: Conference contribution

Publication year: 2022

Journal

Publisher: ELSEVIER

City/Town: AMSTERDAM

Pages Range: S805-S805

Conference Proceedings Title: ANNALS OF ONCOLOGY

Event location: Online

DOI: 10.1016/j.annonc.2022.07.689

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Hampl, M., Jaeger, A., Eulenburg, C., Prieske, K., Hambrecht, J., Fuerst, S.,... Woelber, L. (2022). When to treat the pelvis in node-positive vulvar cancer: Results from the AGO-VOP.2 QS vulva study. In ANNALS OF ONCOLOGY (pp. S805-S805). Online: AMSTERDAM: ELSEVIER.

MLA:

Hampl, M., et al. "When to treat the pelvis in node-positive vulvar cancer: Results from the AGO-VOP.2 QS vulva study." Proceedings of the Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), Online AMSTERDAM: ELSEVIER, 2022. S805-S805.

BibTeX: Download